Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

In a major move, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is acquiring most of 23andMe’s assets for $256 million, including its personal genome service, research services, biobank, and ...

Regeneron Pharmaceuticals, Inc. (REGN) Acquires 23andMe Assets in $256M Deal Published on July 25, 2025 at 10:39 pm by Laiba Immad in News ...